This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Universidade Federal De Minas Gerais. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Innovations of Rodrigo Araújo Fraga Da Silva
Introduction: Rodrigo Araújo Fraga Da Silva is an accomplished inventor based in Belo Horizonte, Brazil. He has made significant contributions to the field of biomedical research, particularly in the development of novel therapeutic agents.
Latest Patents: Rodrigo holds a patent related to the peptide Des-[Asp]-[Ala]-Angiotensin-(1-7) (Ala-Arg-Val-Tyr-Ile-His-Pro) (SEQ ID NO: 1). This invention focuses on its use as a vasodilating and cardioprotective agent in mammals. The patent also encompasses the production of compounds containing Des-[Asp]-[Ala]-Angiotensin-(1-7) and its related compounds, along with methods for treating and preventing diseases.
Career Highlights: Rodrigo is affiliated with the Universidade Federal De Minas Gerais, where he engages in research and development activities. His work has been instrumental in advancing the understanding of cardiovascular health and potential treatments.
Collaborations: He has collaborated with notable colleagues, including Robson Augusto Souza Dos Santos and Anderson José Ferreira, contributing to a dynamic research environment.
Conclusion: Rodrigo Araújo Fraga Da Silva exemplifies innovation in the biomedical field through his patent and collaborative efforts. His work continues to pave the way for advancements in health and medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile